Program
#3 Cancer: Comprehensive [Alternative Set]: 0.12, 0.25, 0.7, 5.03, 15.61, 17.5, 31.2, 95.5, 425.58, 434.72
In 2017, ETDFL introduced Program #3, the Alternative Cancer Treatment Frequency Group, designed as a complementary and alternative option for patients seeking non-invasive, frequency-based cancer therapy. This program included a unique set of frequencies—0.12 kHz, 0.25 kHz, 0.7 kHz, 5.03 kHz, 15.61 kHz, 17.5 kHz, 31.2 kHz, 95.5 kHz, 425.58 kHz, and 434.72 kHz—carefully selected based on comprehensive research into disease frequencies and their therapeutic potential. This set of frequencies was developed by the ETDFL Data Group, sourced from 12 clinics utilizing the Quantum SCIO Bioresonance Machine, which recorded disease frequencies of actual clients over time. By analyzing these frequencies, the group was able to identify the ten most accurate and effective frequencies to treat a wide variety of cancers, ensuring that the therapy was both targeted and adaptable to individual needs.
This Alternative Cancer Group was designed to address a wide range of cancers, from Adrenocortical Cancer and Bladder Cancer to more complex conditions like Neuroblastoma and Thymoma Cancer. Patients using this program could target the frequencies specific to their condition, supporting a holistic approach to cancer treatment. The system allowed the frequencies to be transmitted through light, utilizing the BeamRay white light mat and the infrared light mat, both of which were key components of the treatment. The mats, designed to emit these frequencies in both visible and infrared light waves, provided a non-invasive method for frequency delivery. The infrared mat, in particular, penetrated deeper into the body’s tissues, while the white light mat offered broader exposure, ensuring that the frequencies reached their target areas.
For patients, the process was simple yet effective. They would wrap the mats around the point of concern on their body, whether it was the abdomen for gastrointestinal cancers, the chest for lung cancer, or the head for brain tumors. The light emitted from the mats, which carried the therapeutic frequencies, would interact with the body’s cells, creating a gentle resonance effect designed to support healing and balance. The user-friendly BeamRay controller allowed patients to select treatment durations based on their needs, with time options of 30 minutes, 60 minutes, 90 minutes, or 120 minutes, offering flexibility in how long they wished to receive therapy. This timer ensured that each session was consistent and adhered to a structured treatment protocol.
The Alternative Cancer Treatment Frequency Group proved to be highly effective and was widely adopted by patients seeking a natural alternative to traditional cancer therapies. Over the next eight years, clients reported significant benefits from using this program as part of their treatment plans. Whether as a primary therapy or a complementary treatment alongside conventional medical care, the frequencies in Program #3 helped many patients manage their cancer more effectively, reducing symptoms and improving overall well-being.
The success of the Alternative Cancer Group was grounded in the data-driven approach of the ETDFL Data Group, whose work with the Quantum SCIO Bioresonance Machine allowed them to create a set of frequencies tailored to the unique disease frequencies of each patient. By gathering data from 12 clinics worldwide, they were able to produce a highly accurate treatment group that was directly aligned with the body’s natural healing processes. This development reflected Dr. Rife’s original vision: to use electromagnetic frequencies to stimulate the body’s ability to heal itself, without harmful side effects.
As a result, the BeamRay program quickly became recognized as a groundbreaking alternative cancer treatment, offering patients a safe, non-invasive therapy option. The Alternative Cancer Treatment Frequency Group’s foundation in actual patient data from bioresonance machines set it apart from traditional cancer therapies, offering a unique approach that respected the individuality of each person’s disease and healing process.
The continuing success of this alternative treatment group helped solidify BeamRay’s position at the forefront of modern frequency medicine, drawing upon Dr. Rife's pioneering work while integrating the latest scientific methods to support patients on their journey toward healing. By adhering to the original principles of frequency therapy and coupling them with state-of-the-art technology, the BeamRay system provided an alternative path for those seeking holistic cancer treatments, empowering patients with an innovative way to manage their health in a way that aligned with their personal healing preferences.
Program 3 is an alternate set that can be used for the treatment of
Adrenocortical Cancer, Bladder Cancer, Bone Cancer, Brain Tumor Cancer, Brain Stem Glioma Cancer, Cerebellar Astrocytoma Cancer, Cerebral Astrocytoma Cancer, Ependymoma Cancer, Medulloblastoma Cancer, S.P.N. & Pineal Tumors Cancer, Visual Pathway and Hypothalamic Glioma Cancer, Breast Cancer, Cervical / Uterus Cancer, Colon Cancer, Digestive System Cancer, Ear Cancer, Endocrine Gland Cancer, Endometrium Cancer, Esophageal Cancer, Ewings PNET Primitive Neuroectodermal Tumor Cancer, Extracranial Germ Cell Tumor Cancer, Extrahepatic Bile Duct Cancer, Eye Cancer, Gallbladder Cancer, Gastric Stomach Cancer, Gastrointestinal Cancer, Genital Female Cancer, Genital Male Cancer, Germ Cell Cancer, Gestational Tumor Cancer, Head and Neck Cancer, Hypopharyngeal Cancer, Intestinal Gastrointestinal Cancer, Islet Cell Carcinoma Cancer, Kidney Renal Cancer, Larynx Cancer, Leukemia Cancer, Leukemia Acute Myeloid Cancer, Leukemia Chronic Lymph Cancer, Leukemia Hairy Cell Cancer, Leukemia Lymphoblastic Cancer, Leukemia Myelogenous Cancer, Lip and Oral Cavity Cancer, Liver Cancer, Lung Non-Small Cell Cancer, Lung Small Cell Cancer, Lymphoma Cancer, Lymphoma B-Cell Cancer, Lymphoma Malignant Cancer, Lymphoma Non-Hodgkin Cancer, Lymphoma T-Cell Cancer, Lymphoplasmacytic Cancer, Malignant Mesothelioma Cancer, Melanoma Cancer, Merkel Cell Cancer, Metastasis Squamous Cancer, Mouth Cancer, Multiple Myeloma inc Plasma C Cancer, Mycosis Fungoides Cancer, Myelodysplastic Syndrome Cancer, Myeloproliferative Disorders Cancer, Nasopharyngeal Cancer, Nervous System Neoplasms Cancer, Neuroblastoma Cancer, Oral Cancer, Oropharyngeal Cancer, Otorhinolaryngologic Cancer, Ovarian Cancer, Ovarian Epithelial Cancer, Ovarian Germ Cell Cancer, Ovarian Low Malignant Potential Tumor Cancer, Pancreatic, Exocrine & Islet Cell Cancer, Paranasal Sinus and Nasal Cavity Cancer, Parathyroid Cancer, Penile [Penis] Cancer, Pheochromocytoma [Non-Benign] Cancer, Pituitary Cancer, Plasma Cell Neoplasm Cancer, Prostate Cancer, Rectal [Rectum] Cancer, Renal Cell [Kidney] Cancer, Residual Cancer, Respiratory Tract Cancer, Rhabdomyosarcoma Cancer, Salivary Gland Cancer, Sarcoma General Cancer, Sezary Syndrome Cancer, Skin Cancer, Skin Kaposi’s Sarcoma Cancer, Skin Melanoma Cancer, Skin T-Cell Lymph Cancer, Small Intestine Cancer, Soft Tissue Sarcoma Cancer, Squamous Cell Carcinoma Cancer, Stomach Cancer, Testicular [Testis] Cancer, Thoracic Cancer, Thymoma Cancer, Thyroid Cancer, Tonsil Cancer, Trophoblastic Cancer, Urethral [Urinary] Cancer, Urinary Bladder Cancer, Urologic Neoplasms Cancer, Uterine Sarcoma Cancer, Uterine Cervical Cancer, Vaginal Cancer, Vulvar Cancer, Wilms Tumor Cancer, Womb Cancer.
BeamRay Infrared Therapy Device
Supporting Recovery and Pain Relief with Advanced Infrared Technology for Cancer Care
5 Treatment Modes
● BeamRay™ Original
● Cancer Comprehensive
● Cancer Comp (Alternative Set)
● Cancer Metastasis
● Dr Rife’s Specialized MOR CW
Automatic Timer
Automatic timer permits 30,60,90 and 120 minutes
Comes with Adjustable Strap
The BeamRay device features an adjustable velcro strap, offering a universal fit that ensures the device stays comfortably and securely in place on any targeted area for all users.
BeamRay Therapy Device
Advanced BeamRay Technology for Cancer Care
Multiple BeamRay Light Mats
● BeamRay White Light Mat
● BeamRay Infrared Light Mat
Adjustable Intensity
Adjustable Intensity
Switch from low intensity to High intensity with the press of a button
140 Programmable Infrared LEDs
Each of the 140 LEDs on the BeamRay Mats operate on specialized frequency programs tailored to target specific Cancer sites, enhancing the effectiveness of treatment.
This powerful, BeamRay device is designed with 2 mat options. One mat features an array of Visible Infrared RED LED lights, with each mat containing 140 LEDs optimized for targeting cancers. The 2nd mat is a 140 LED White light mat with an array of White LEDs simulating the original Dr Rife BeamRay. Together, the LED lights work to target various cancer types and assist in treatment and recovery.
